FDA Inspection 1209320 — Garonit Pharmaceutical, Inc.

Garonit Pharmaceutical, Inc. — FEI 3003961853

The FDA completed an inspection of Garonit Pharmaceutical, Inc. on Jul 6, 2023 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 6, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Fairfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.